Trump's Pick To Lead Health Agency Calls EpiPen Issue 'Disturbing'
Category: HEALTHY LIVING
Mylan came under fire last year for misclassifying its lifesaving allergy pen as a generic drug.
By Susan Cornwell, Reuters, 2017-02-17